BackWe Can Medicines , Ltd. Overview

We Can Medicines , Ltd. Current Assets

Latest current assets for 6929.TWO: $1.3B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$1.35B
↓ 6.01% YoYΔ $-86.09M vs prior year quarter

Peer trimmed avg / median

Loading

We Can Medicines , Ltd. Current Assets History

Loading

We Can Medicines , Ltd. vs. peers: Current Assets Comparison

Loading

We Can Medicines , Ltd. Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

We Can Medicines , Ltd. (6929.TWO) FAQ

As of the most recent data (June 2026), 6929.TWO shows a current assets of $1.3B. That compares with $1.4B in the prior-year period — down 6.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6929.TWO's current assets is now $1.3B (was $1.4B) — a 6.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether We Can Medicines , Ltd. is outperforming or lagging.

Tracking 6929.TWO's current assets over time shows whether We Can Medicines , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $1.3B That compares with $1.4B in the prior-year period — down 6.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has We Can Medicines , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $1.3B) with ownership activity and broader fundamentals.